Clene Inc. to Join Benchmark 14th Annual Discovery One-on-One Investor Conference
I'm PortAI, I can summarize articles.
Clene Inc., a biopharmaceutical company, will participate in the Benchmark 14th Annual Discovery One-on-One Investor Conference on December 4, 2025, in New York, hosting one-on-one investor meetings. This event highlights Clene's engagement with investors and its focus on neurodegenerative disease treatments. The news was originally published by Clene Inc. via GlobeNewswire.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments